New HIV prevention drug still needs access and awareness for those in need
|
The arrival of a new HIV drug called lenacapivir is
one of the most talked-about advances in HIV prevention in decades. |
Low CD4 Count Tied to Cervical Cancer Risk in HIV Infection
A lower CD4 count is associated with a higher risk for cervical carcinoma in situ and cervical cancer in women with HIV infection. View article...